MTHFR 677C>T (rsRS1801133) variant is associated with hyperhomocysteinemia but not with clinical severity in patients with peripheral arterial disease
A variante MTHFR 677C>T (RS1801133) está associada a hiperhomocisteinemia, mas não a gravidade clínica em pacientes com doença arterial periférica
Guilherme da Silva Silvestre; Iriana Moratto Carrara; Tamires Flauzino; Marcell Alysson Batisti Lozovoy; Rubens Cecchini; Edna Maria Vissoci Reiche; Andréa Name Colado Simão
Abstract
Keywords
Resumo
Palavras-chave
Referências
1 Breek JC, Hamming JF, De Vries J, Aquarius AE, Van Berge DP. Quality of life in patients with intermittent claudication using the world health organization questionnaire. Eur J Vasc Endovasc Surg. 2001;21(2):118-22.
2 Resnick HE, Lindsay RS, McDermott MM, et al. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study. Circulation. 2004;109(6):733-9.
3 Fowkes FG, Murray GD, Butcher I, et al. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300(2):197-208.
4 Merino J, Planas A, De Moner A, et al. The association of peripheral arterial occlusive disease with major coronary events in a Mediterranean population with low coronary heart disease incidence. Eur J Vasc Endovasc Surg. 2008;36(1):71-6.
5 Fowkes FG, Murray GD, Butcher I, et al. Development and validation of an ankle brachial index risk model for the prediction of cardiovascular events. Eur J Prev Cardiol. 2014;21(3):310-20.
6 Guan X, Yang X, Wang C, Bi R. In silico analysis of the molecular regulatory networks in peripheral arterial occlusive disease. Medicine. 2020;99(21):e20404.
7 Golledge J, Biros E, Bingley J, Iyer V, Krishna SM. Epigenetics and peripheral artery disease. Curr Atheroscler Rep. 2016;18(4):1-9.
8 Krishna SM, Trollope AF, Golledge J. The relevance of epigenetics to occlusive cerebral and peripheral arterial disease. Clin Sci (Lond). 2015;128(9):537-58.
9 Wassel CL, Loomba R, Ix JH, Allison MA, Denenberg JO, Criqui MH. Family history of peripheral artery disease is associated with prevalence and severity of peripheral artery disease: the San Diego population study. J Am Coll Cardiol. 2011;58(13):1386-92.
10 Khaleghi M, Isseh IN, Bailey KR, Kullo IJ. Family history as a risk factor for peripheral arterial disease. Am J Cardiol. 2014;114(6):928-32.
11 Sofer T, Emery L, Jain D, et al. A genome-wide association study in the Hispanic Community Health Study/Study of Latinos. Sci Rep. 2019;9(1):1-11.
12 Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem. 1993;39(9):1764-79.
13 Spark JI, Laws P, Fritidge R. The incidence of hyperhomocysteinemia in vascular patients. Eur J Vasc Endovasc Surg. 2003;26(5):558-61.
14 Venâncio LDS, Burini RC, Yoshida WB Hiper-homocisteinemia na doença arterial periférica. J Vasc Bras. 2004;3(1):31-7.
15 Hainsworth AH, Yeo NE, Weekman EM, Wilcock DM. Homocysteine, hyperhomocysteinemia and vascular contributions to cognitive impairment and dementia (VCID). Biochim Biophys Acta. 2016;1862(5):1008-17.
16 Esse R, Barroso M, Tavares De Almeida I, Castro R. The Contribution of Homocysteine Metabolism Disruption to Endothelial Dysfunction: State-of-the-Art. Int J Mol Sci. 2019;20(4):867.
17 Liew SC, Gupta ED. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases. Eur J Med Genet. 2015;58(1):1-10.
18 Mueller T, Marschom R, Dieplinger B, et al. Leiden, Prothrombin G20210A, and MTHFR C667T mutation are not associated with chronic limb ischemia: the Linz Peripheral arterial disease (LIPAD) study. J Vasc Surg. 2005;41:808-15.
19 Khandanpour N, Willi G, Meyer FJ, Armon MP, Loke YK, Wright AJ. Peripheral arterial disease and methylenetetrahydrofolate reductase (MTHFR) C677T mutations: A case-control study and meta-analysis. J Vasc Surg. 2009;49(3):711-8.
20 Sabino A, Fernandes AP, Lima LM, et al. Polymorphism in the methylenetetrahydrofolate reductase (C677T) gene and homocysteine levels: a comparison in Brazilian patients with coronary arterial disease, ischemic stroke and peripheral arterial obstructive disease. J Thromb Thrombolysis. 2009;27(1):82-7.
21 Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;74(10):1376-414.
22 Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limp-threatening ischemia. Eur J Vasc Endovasc Surg. 2019;58(1):S1-109, 109.e33.
23 Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(Suppl 1):S1-75.
24 Williams B, Mancia G, Spiering W, et al. ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur Heart J. 2018;39(33):3021-104.
25 Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486-97.
26 American Diabetes Association. 2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes -2021. Diabetes Care. 2021;44(Suppl 1):S15-33.
27 Frosst P, Blom HJ, Milos R, et al. A candidate gene risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10(1):111-3.
28 Riba R, Nicolaou A, Troxler M, Homer-Vaniasinkam S, Naseem KM. Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels. Atherosclerosis. 2004;175(1):69-75.
29 Guo XW, Dudman NPB. Homocysteine alters interactions between neutrophils and vascular endothelial cells in vitro. Atherosclerosis. 1997;134(1-2):255-255.
30 Arruda VR, Siqueira LH, Gonçalves MS, et al. Prevalence of the mutation C677 T in the methylenetetrahydrofolate reductase gene among distinct ethnic groups in Brazil. Am J Med Genet. 1998;78(4):332-5.
31 Richter V, Janke C, Purschwitz K, et al. Plasma homocysteine and lipoprotein profile in patients with peripheral arterial occlusive disease. Angiology. 2000;51(3):189-96.
32 Cappuccio FP, Bell R, Perry IJ, et al. Homocysteine levels in men and women of different ethnic and cultural background living in England. Atherosclerosis. 2002;164(1):95-102.
33 Fowkes FG, Lee AJ, Hau CM, Cooke A, Connor JM, Lowe GD. Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh Artery Study. Atherosclerosis. 2000;150(1):179-85.
34 Crowther MA, Kelton JG. Congenital thrombophilic states associated with venous thrombosis: a qualitative overview and proposed classification system. Ann Intern Med. 2003;138(2):128-34.
35 Stricker H, Soldati G, Balmelli T, Mombelli G. Homocysteine, vitamins and gene mutations in peripheral arterial disease. Blood Coagul Fibrinolysis. 2001;12(6):469-75.
36 Leeper NJ, Kullo IJ, Cooke JP. Genetics of peripheral artery disease. Circulation. 2012;125(25):3220-8.
37 Belkin N, Damrauer SM. Peripheral arterial disease genetics: progress to date and challenges ahead. Curr Cardiol Rep. 2017;19(12):131.
38 Castro R, Rivera I, Ravasco P, et al. 5,10-methylenetetrahydrofolate reductase (MTHFR) 677C → T and 1298A → C mutations are associated with DNA hypomethylation. J Med Genetics. 2004;41(6):454-8.
39 Sam RC, Burns PJ, Hobbs SD, et al. The prevalence of hyperhomocysteinemia. methylene tetrahydrofolate reductase C677T mutation. and vitamin B12 and folate deficiency in patients with chronic venous insufficiency. J Vasc Surg. 2003;38(5):904-8.
40 Wilmanns C, Casey A, Schinzel H, Walter PK. Superficial thrombophlebitis in varicose vein disease: the particular role of methylenetetrahydrofolate reductase. Phlebology. 2011;26(4):135-9.
Submetido em:
06/07/2022
Aceito em:
18/05/2023
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email